jultucuydegufum
40 posts
Jun 20, 2025
4:06 AM
|
Malegra DXT Plus is a combination medication containing sildenafil citrate and dapoxetine, used to treat erectile dysfunction and premature ejaculation. Regarding who first tested Malegra DXT Plus specifically on humans, there is no publicly available detailed information identifying a single individual or research team responsible for the first human trials of this branded combination product.
However, the active ingredients—sildenafil and dapoxetine—have undergone extensive clinical testing separately and in combination by pharmaceutical companies and research organizations. Sildenafil, the key ingredient originally developed by Pfizer as Viagra, was first tested on humans in the late 1990s. Dapoxetine, a selective serotonin reuptake inhibitor (SSRI) for premature ejaculation, was later developed and tested by companies such as Johnson & Johnson.
Malegra DXT Plus is produced by Sunrise Remedies Pvt. Ltd., a pharmaceutical company that markets this combination drug. It is likely that Sunrise Remedies conducted clinical evaluations or relied on existing clinical data for the individual components to ensure safety and efficacy before launching the product. Such trials are typically conducted under strict regulatory guidelines but specific details about the first human testing of Malegra DXT Plus are not widely published.
In conclusion, while the individual drugs have well-documented human trials, the exact identity of the first person or team to test Malegra DXT Plus on humans is not publicly known.
|
